MDXG : Summary for MiMedx Group, Inc - Yahoo Finance

U.S. Markets closed

MiMedx Group, Inc. (MDXG)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.67-0.03 (-0.31%)
At close: 4:00PM EDT

9.70 0.03 (0.36%)
After hours: 4:13PM EDT

People also watch
OSIRNEOMACKHALOIRWD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close9.70
Open9.70
Bid9.68 x 5000
Ask9.69 x 1800
Day's Range9.52 - 9.85
52 Week Range6.64 - 10.02
Volume688,276
Avg. Volume786,119
Market Cap1.05B
Beta0.83
PE Ratio (TTM)87.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    MiMedx To Present At The 16th Annual Needham Healthcare Conference

    MARIETTA, Ga., March 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected ...

  • PR Newswire10 days ago

    MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors

    MARIETTA, Ga., March 19, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the U.S. Securities and Exchange Commission (SEC) and highly accomplished lawyer within industry and private law practice, as an independent, non-employee Director of the MiMedx Board of Directors. Parker H. "Pete" Petit, Chairman and CEO, said, "MiMedx is very fortunate to have an extremely accomplished Board of Directors.

  • PR Newswire21 days ago

    MiMedx To Present At Canaccord's 12th Annual Musculoskeletal Conference

    MARIETTA, Ga., March 8, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human placental tissue allografts and other birth tissues, human skin ...